Searchable abstracts of presentations at key conferences in endocrinology

ea0026p285 | Pituitary | ECE2011

Pituitary calf transplantation into the human, 50 years after

Marczewski K , Gasiorek M , Maciejewski M , Wszola-Kleinrok J

Introduction: Hundred years ago Harvey Cushing attempt first human pituitary transplantation. This operation, in different modifications, was performed in the next 50 years, but now is used rather only in animal experiment. The problem of effective therapy of hypopituitarism, other that substitution, is however still open. That encouraged us to present a patient 50 years after pituitary xenotransplantation.Case: A 75-year-old woman was admitted to hospit...

ea0029p1166 | Nuclear receptors and Signal transduction | ICEECE2012

Evaluation of K+ flux-dependent regulation of mitochondrial potential (ΔΨm) by α-adrenergic agonist phenylephrine in single hepatocytes

Malyukina M. , Kavok N.

It is generally accepted that hepatic responses to α-adrenergic agonists are dependent on the redistribution of intracellular and also extracellular Ca2+. Besides, phenylephrine induces significant K+ flux changes and plasma membrane hyperpolarisation. Earlier it was shown that K+ channel blockers as well as chelating of extracellular Ca2+ with EGTA could inhibit phenylephrine-induced metabolic responses and activation of mitoch...

ea0049ep598 | Diabetes therapy | ECE2017

The hypolipidemic and hepatoprotective efficacies of a fixed-dose combination of essential phospholipids with methionine (EPL+M) during atorvastatin (A) therapy in hyperlipidemic patients with cardiovascular diseases (CVD) and type 2 diabetes mellitus (DM) (OLYMP trial)

Bubnova M G , Aronov D M , Bubnoa Marina , Aronov David

Objective: Objective to study the hypolipidemic efficacy, hepatoprotective activity, and tolerance of the fixed-dose combination of essential phospholipids with methionine (EPL+M) - Eslidine in the combination therapy with A in patients (pts) with cardiovascular diseases (CVD) and type 2 DM who suffer from hyperlipidemia (HL) in order to optimize their treatment in daily clinical practice.Subjects and methods: The trial enrolled 60 pts (mean age 58.1&#17...

ea0032p202 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2013

Dyslipidemia associated with m-TOR inhibitors treatment

Couto Joana , Martins Raquel , Carneiro Filipa , Santos Ana Paula , Torres Isabel

Introduction: Therapeutic approach of patients (pts) with metastatic renal cell carcinoma (mRCC) may include the use of biological agents such as m-TOR inhibitors: temsirolimus (TM) and everolimus (EV). Its use is associated with metabolic dysfunction, especially with everolimus: hyperglycemia (37% TM treated pts vs 72% EV treated pts), hypercholesterolemia (25% TM treated pts vs 81% EV treated pts) and hypertriglyceridemia (30% TM treated pts vs 73% EV treated pts). Discontin...

ea0029p967 | Female Reproduction | ICEECE2012

Serum 17β-estradiol concentration and depression symptoms presence in climacteric women

Slopien R. , Maciejewska M. , Warenik-Szymankiewicz A.

We studied 74 women admitted to the Department of Gynecological Endocrinology University of Medical Sciences of Poznan because of climacteric symptoms. All the studied women were older than 40 years of age, all were still menstruating or had their last menstruation not later than 1 year ago.The aim of the study was evaluation of possible relationship between serum 17β-estradiol concentration and depression symptoms presence in climacteric women....

ea0011p782 | Thyroid | ECE2006

Correlation between endogenous thyroxin and A, G, and M immunoglobulins in dysthyreosis

Laszlo A , Pascanu I , Gliga C , Schiopu A , Laszlo M

Introduction: The thyroid is a multifunctional endocrine gland which, by its hormones, affects all the organs, metabolisms and nonspecific defence of the body. The aim of this study is to establish if endogenous thyroxin (FT4) is involved in the nonspecific defence of the organism.Material and methods: 94 patients were included in the study, 47 with hyperthyroidism and 47 with hypothyroidism, 81 women, 13 men aged 7–78. FT4 was...

ea0026p106 | Female reproduction | ECE2011

C-peptide serum concentration in obese women with polycystic ovary syndrome

Maciejewska-Jeske M M J , Szczesna A S , Meczekalski B M

Introduction: It is believed that key pathogenic mechanism of PCOS is hyperinsulinemia. Insulin synthesis is linked to C-peptide release, but the role of C-peptide in PCOS remains unknown.Methods: The aim of this study was to evaluate of C-peptide serum levels in obese women with PCOS with concomitant assessment of possible link between C-peptide concentrations and metabolic disturbances and androgens levels in those individuals.Si...

ea0029p598 | Diabetes | ICEECE2012

Prevalence of diabetes-associated antibodies and impaired insulin response to glucose in first degree relatives of diabetic patients Ebtissam M. Salah*, Hesham El-Hafnawy**, Mona Anwar*, Samar M. E. Salem*, Mai M. Youssef*, Atef Bassyoni** and Marry Aziz**

El Hefnawy M.

Type 1 diabetes is a chronic autoimmune disease with a subclinical prodromal period characterized by the presence of circulating antibodies to various islet cell proteins. Our main objective is to estimate the prevalence of diabetes-associated autoantibodies in a group of 1st degree relatives, compared to healthy control subjects. Also, we tried to assess the insulin secretory capacity in subjects having multiple antibodies using first phase insulin response (FPIR) to intraven...

ea0041ep1124 | Thyroid cancer | ECE2016

Adjuvant metformin (M) therapy in differentiated thyroid carcinoma (DTC)

Balestra Margherita , Gay Stefano , Pera Giorgia , Mortara Lorenzo , Monti Eleonora , Giusti Massimo

M shows an antiproliferative effect. In vivo, M reduces TSH in type 2 diabetes mellitus (T2DM) and DTC aggressiveness in DTC with T2DM. The aim of the study was to evaluate in DTC diabetic (Gr1, n=30 under M 1500 mg/day) and non-diabetic without (Gr2, n=83) or under M (gr3, n=84; M 1000 mg/day) the adjuvant role of M. Clinical and laboratory examinations were performed up to 24 months. At baseline the DTC groups were similar for age, gender, tumor st...

ea0029p1283 | Obesity | ICEECE2012

Study of insulin resistance in overweight and obese children by: M Hesham El Hefnawy and Ibrahim Emara

Hefnawy M. El

Obesity is a major risk factor for chronic non communicable diseases and plays a central role in the insulin resistance or metabolic syndrome, which includes hyperinsulinemia, hypertension, hyperlipidemia, type 2 diabetes mellitus, and an increased risk of adult onset obesity and atherosclerotic cardiovascular disease (1). Insulin resistance is a state in which a given concentration of insulin produces a less than expected biological effect. The metabolic syndrome is a cluster...